Milestone Scientific Company Insiders
| MLSS Stock | USD 0.25 -0.04 -13.79% |
Milestone Scientific's insiders are aggressively buying. The analysis of insiders' sentiment of trading Milestone Scientific stock suggests that virtually all insiders are extremely bullish at this time. Milestone Scientific employs about 17 people. The company is managed by 10 executives with a total tenure of roughly 19 years, averaging almost 1.0 years of service per executive, having 1.7 employees per reported executive.
| Leonard Osser CEO CEO and Director |
| James McAvinn President Senior Vice President - Sales & Marketing |
Insider Sentiment
Aggressively Buying
Selling | Buying |
Latest Trades
| 2022-06-16 | GOLDMAN NEAL I | Acquired 9720 @ 0.75 | View | ||
| 2022-06-15 | GOLDMAN NEAL I | Acquired 5270 @ 0.8 | View |
Following insider trading sentiment in Milestone Scientific can help investors add context around confidence, timing, and operating risk while the public narrative is still evolving. The stronger workflow is to compare insider behavior with earnings, guidance, and business changes instead of reading the transactions in isolation.
Milestone | Build portfolio with Milestone Stock |
Management Team Effectiveness
The company has return on total asset (ROA) of -42.34 % which means that it generated a loss of $42.34 on every $100 of assets employed. This places it below most industry peers. Similarly, it shows a return on stockholder's equity (ROE) of -136.47 %, which indicates that equity investment in it has not been earning a positive return.As of the week of March 21, Common Stock Shares Outstanding is projected to grow to approximately 96.3 M, even as demand moderates, Net Loss is positioned to soften to slightly above -6.4 M.
Insider Trading Activities
Tracking Milestone Scientific's insider filings adds context. Executives often respond to business conditions well before market sentiment shifts. The goal is to tell routine pay-related sales apart from trades that reflect genuine conviction.
Outstanding Bonds
Reviewing Milestone Scientific bond obligations provides context for understanding how much of the business is financed with fixed-income capital rather than purely with equity. Current market capitalization is about 19.37 Million. Bond investors and equity investors often care about the same cash flows, but they rank the risks differently.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Shares in Circulation | First Issued 1996-06-30 | Previous Quarter 82 M | Current Value 82.3 M | Average Shares Outstanding 25.7 M | Quarterly Volatility 25.3 M |
Macro event markers
Holders Distribution
Institutional investors in Milestone Scientific typically operate with more research capacity, technology, and trading scale than retail holders, which is why their activity can materially affect price behavior. The opportunity for retail investors is not to imitate blindly, but to understand how large-holder positioning may affect liquidity, volatility, and timing.
Market Cap and Value
Workforce Comparison
Milestone Scientific is rated below average in number of employees relative to competitors. The total workforce of Health Care industry is now estimated at about 1,029. Milestone Scientific claims roughly 17.0 in number of employees contributing just under 2% to equities under Health Care sector.
Profit Margins
The company has Profit Margin (PM) of -75.0 %, which suggests that margin recovery will require either cost cuts or price increases. This places it below most industry peers. Similarly, it shows Operating Margin (OM) of -48.0 %, which suggests that operating leverage is working against the company at current revenue levels.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.46 | 0.67 |
|
|
Insider Trading History
Milestone Scientific's insider log provides a timeline of management conviction alongside earnings and guidance changes. Current market capitalization is about 19.37 Million. Larger blocks and clustered timing carry more weight than isolated trades.
Notable Stakeholders
Stakeholder analysis for Milestone Scientific is useful because companies often face trade-offs among groups that want very different outcomes from the same business. This becomes more informative when investors want to understand not just ownership, but influence, incentives, and strategic pressure points.
| Leonard Osser | CEO and Director | Profile | |
| Neal CFA | Chairman CEO | Profile | |
| Jan Haverhals | President Director | Profile | |
| James McAvinn | Senior Vice President - Sales & Marketing | Profile | |
| Eric Hines | President Officer | Profile | |
| James JD | Senior Development | Profile | |
| MS MBA | Vice Finance | Profile | |
| Jason Papes | Senior Marketing | Profile | |
| Andy Molnar | Senior Dental | Profile | |
| Keisha Harcum | Controller | Profile |
Management Information & Data Sources
Milestone Scientific is a micro-cap company in Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care. Executive review focuses on insiders, senior management, and employee signals. Organizational trends can support analysis of efficiency, oversight, and decision-making consistency. CEO is Leonard Osser with 17 employees and 10 reported executives.
The analytics block for Milestone Scientific relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Timing can vary by data vendor. Insider and management fields are mapped from published filings and company disclosures.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardWorkforce Efficiency and Productivity
Workforce metrics tied to Milestone Scientific offer a useful way to test whether headcount and economic output are moving in a productive direction. A disciplined workforce review can reveal whether execution quality is improving beneath the top-line numbers.
Milestone Scientific Manpower Efficiency
Return on Milestone Scientific Manpower
| Revenue Per Employee | 507.6K | |
| Revenue Per Executive | 863K | |
| Net Loss Per Employee | 277.3K | |
| Net Loss Per Executive | 471.4K | |
| Working Capital Per Employee | 326K | |
| Working Capital Per Executive | 554.2K |
Additional Tools for Milestone Stock Analysis
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |